Treatment of Kaposis Sarcoma

[1]  P. Moore,et al.  Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV8) and the Etiology of KS , 2002 .

[2]  A. Tulpule,et al.  Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Buskin,et al.  DECLINE IN HIV-ASSOCIATED KAPOSI'S SARCOMA (KS) AND NON-HODGKIN'S LYMPHOMA (NHL) FOLLOWING THE INTRODUCTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART). , 1999 .

[4]  K. Fife,et al.  Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre , 1998, International journal of STD & AIDS.

[5]  A. Tulpule,et al.  Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M A Fischl,et al.  Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Singer,et al.  Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  L. Jacobson.  Impact of Ilighly Effective Anti-retroviral Therapy on the Incidence of Malignancies Among HIV-infected Individuals , 1998 .

[9]  J. V. Von Roenn,et al.  Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Stewart,et al.  Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  F. Reichenberger,et al.  Diagnosis of pulmonary Kaposi's sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage. , 1998, American journal of respiratory and critical care medicine.

[12]  M. Testa,et al.  AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[14]  D. Ganem,et al.  Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. , 1997, The Journal of clinical investigation.

[15]  R. Wittes,et al.  KAPOSI'S SARCOMA RESPONSE CRITERIA: ISSUES IDENTIFIED BY THE NATIONAL CANCER INSTITUTE, FOOD AND DRUG ADMINISTRATION, AND THE AIDS MALIGNANCY CONSORTIUM , 1997 .

[16]  P. Swift.  The role of radiation therapy in the management of HIV-related Kaposi's sarcoma. , 1996, Hematology/oncology clinics of North America.

[17]  B. Gazzard,et al.  Anti‐herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection , 1996, AIDS.

[18]  J. V. Von Roenn,et al.  Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Phair,et al.  Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. , 1996, The Journal of infectious diseases.

[20]  D. Finkelstein,et al.  A Phase II Study of Recombinant Human Interferon-α2a and Zidovudine in Patients with AIDS-Related Kaposi's Sarcoma , 1996 .

[21]  D R Hoover,et al.  Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.

[22]  S. Mauss,et al.  efficacy, Safety, and Tolerance of Low-dose, Long-term Interferon-α2b and Zidovudine in Early-stage Aids-associated Kaposi's Sarcoma , 1995 .

[23]  L. Kingsley,et al.  Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  W. Wilson,et al.  Treatment of HIV-associated Kaposi's sarcoma with paclitaxel , 1995, The Lancet.

[25]  C. Flaitz,et al.  Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS. , 1995, European journal of cancer. Part B, Oral oncology.

[26]  J. Kahn,et al.  Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group. , 1995, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

[27]  T. Kuzel,et al.  Hand‐foot syndrome associated with liposome‐encapsulated doxorubicin therapy , 1995, Cancer.

[28]  S. Stewart,et al.  Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  J. Melamed,et al.  Kaposi's sarcoma of internal organs. A multiparameter study of 86 cases , 1995, Cancer.

[30]  G. Webster.  Local Therapy for Mucocutaneous Kaposi's Sarcoma in Patients with Acquired Immunodeficiency Syndrome , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[31]  R. van Leusen,et al.  Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF). , 1995, European journal of cancer.

[32]  P. Piedbois,et al.  Radiotherapy in the management of epidemic Kaposi's sarcoma. , 1994, International journal of radiation oncology, biology, physics.

[33]  S. Remick,et al.  Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  S. Sahn,et al.  Endobronchial lesions in HIV-infected individuals. , 1994, Chest.

[35]  Y. Barenholz,et al.  Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. , 1994, Cancer research.

[36]  F. Goebel,et al.  Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma. , 1994, Journal of acquired immune deficiency syndromes.

[37]  K. Stelzer,et al.  A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma. , 1993, International journal of radiation oncology, biology, physics.

[38]  E. Sloand,et al.  Chemotherapy for Patients With Pulmonary Kaposi's Sarcoma: Benefit of Filgrastim (G‐CSF) in Supporting Dose Administration , 1993, Southern medical journal.

[39]  C. Flaitz,et al.  Treating Kaposi's lesions in the HIV-infected patient. , 1993, Journal of the American Dental Association.

[40]  R. Gallo,et al.  The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Presant,et al.  Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma , 1993, The Lancet.

[42]  J. Kahn,et al.  Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. , 1993, Journal of acquired immune deficiency syndromes.

[43]  C. Katlama,et al.  AIDS‐associated mucocutaneous Kaposi's sarcoma treated with bleomycin , 1992, AIDS.

[44]  S. Stewart,et al.  Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin , 1992, AIDS.

[45]  D. R. Parker,et al.  Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanning. , 1991, Radiology.

[46]  M. E. Harb,et al.  Treatment of Advanced Kaposi's Sarcoma Using a Combination of Bleomycin and Vincristine , 1990, American journal of clinical oncology.

[47]  A. Levine,et al.  Advanced acquired immune deficiency syndrome‐related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy , 1990, Cancer.

[48]  S. Krown,et al.  Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  S. Krown,et al.  Kaposi's Sarcoma in the Acquired Immune Deficiency Syndrome: A Proposal for Uniform Evaluation, Response, and Staging Criteria , 1989 .

[50]  P. Volberding,et al.  Treatment of Kaposi's sarcoma with interferon alfa‐2b (Intron® A) , 1987, Cancer.

[51]  P. Volberding,et al.  Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. , 1986, Cancer treatment reports.

[52]  D. Stover,et al.  Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical, radiographic, and pathologic manifestations. , 1986, The American journal of medicine.

[53]  K. Vranizan,et al.  Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. , 1985, Annals of internal medicine.

[54]  Niedt Gw,et al.  Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies. , 1985 .

[55]  F. Real,et al.  Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. , 1985, Annals of internal medicine.

[56]  F. Muggia,et al.  Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  A. Clemett,et al.  The familial occurrence of infantile cortical hyperostosis. , 1963, Radiology.